Stocktoria

Jin Medical International Ltd. ZJYL

Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
3/9
Piotroski F — financial health
5.16
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022
Financials
Revenue$20.7M$23.5M$19.8M$19.2M
Gross profit$6.0M$9.5M$6.8M$6.2M
Operating income$608,182$3.6M$2.9M$2.1M
Net income$1.2M$3.7M$2.9M$2.7M
Operating cash flow$2.9M-$1.2M$3.1M$1.6M
Free cash flow-$3.7M-$1.4M$3.0M$1.5M
Total assets$53.4M$45.8M$32.9M$20.9M
Total liabilities$23.8M$17.2M$8.9M$5.7M
Shareholders' equity$29.6M$28.8M$24.0M$15.2M
Ratios
Gross margin29.2%40.4%34.2%32.3%
Operating margin2.9%15.5%14.5%11.1%
Net margin5.8%15.6%14.5%14.1%
FCF margin-18.0%-5.8%15.1%8.0%
Return on assets2.2%8.0%8.7%12.9%
Return on equity4.0%12.8%12.0%17.8%
Current ratio1.862.503.493.31
Revenue growth-12.0%18.6%3.3%

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 5.16 (safe)

  • Working capital / assets 0.381
  • Retained earnings / assets 0.392
  • EBIT / assets 0.011
  • Equity / liabilities 1.243

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001837821 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.